Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Julaine Braham"'
Autor:
Stephen Bell MD, Natalia Lattanzio MD, Julaine Braham MD, Victoria Campdesuner DO, Qassem Abdelal MD, Alexander Vartanov MD, Miguel Pelayo MD
Publikováno v:
Journal of Investigative Medicine High Impact Case Reports, Vol 9 (2021)
B-cell prolymphocytic leukemia (B-PLL) is a rare leukemia characterized by rapidly increasing leukocytosis with splenomegaly and lymphadenopathy. Treatment strategies are largely based on studies of chronic lymphocytic leukemia (CLL). Antibodies agai
Externí odkaz:
https://doaj.org/article/c252a5c5f33149f191f0aa08072ad9dc
Autor:
Alexander Vartanov, Victoria Campdesuner, Miguel Pelayo, Qassem Abdelal, Stephen Bell, Julaine Braham, Natalia Lattanzio
Publikováno v:
Journal of Investigative Medicine High Impact Case Reports, Vol 9 (2021)
Journal of Investigative Medicine High Impact Case Reports
Journal of Investigative Medicine High Impact Case Reports
B-cell prolymphocytic leukemia (B-PLL) is a rare leukemia characterized by rapidly increasing leukocytosis with splenomegaly and lymphadenopathy. Treatment strategies are largely based on studies of chronic lymphocytic leukemia (CLL). Antibodies agai
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::999fd796073a006d8891a783331550e9
https://doaj.org/article/c252a5c5f33149f191f0aa08072ad9dc
https://doaj.org/article/c252a5c5f33149f191f0aa08072ad9dc
Autor:
Lisette Patricia Rodriguez, Vida Farhangi, Julaine Braham, Robert A Smith, Wilhelmine Wiese-Rometsch
Publikováno v:
Journal of the Endocrine Society
Introduction: Evidence establishes that COVID-19 patients with DM2 are at increased risk for severe disease and worse outcomes. Peer reviewed data is sparse comparing glycemic control and clinical outcomes among COVID-19 patients with vs. without DM2
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c6cdff25b2c6045854af955e91e57847
http://europepmc.org/articles/PMC8089908
http://europepmc.org/articles/PMC8089908